• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成鸡蛋白氨酸酰胺 A 类似物作为有效的疟原虫蛋白酶抑制剂和抗疟药物。

Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.

机构信息

School of Chemistry, The University of Sydney , Building F11, Sydney, New South Wales 2006, Australia.

出版信息

J Med Chem. 2014 Dec 26;57(24):10557-63. doi: 10.1021/jm501439w. Epub 2014 Dec 8.

DOI:10.1021/jm501439w
PMID:25412465
Abstract

Analogues of the natural product gallinamide A were prepared to elucidate novel inhibitors of the falcipain cysteine proteases. Analogues exhibited potent inhibition of falcipain-2 (FP-2) and falcipain-3 (FP-3) and of the development of Plasmodium falciparum in vitro. Several compounds were equipotent to chloroquine as inhibitors of the 3D7 strain of P. falciparum and maintained potent activity against the chloroquine-resistant Dd2 parasite. These compounds serve as promising leads for the development of novel antimalarial agents.

摘要

为了阐明新型恶性疟原虫半胱氨酸蛋白酶抑制剂,我们制备了天然产物加林酰胺 A 的类似物。类似物对疟原虫半胱氨酸蛋白酶-2(FP-2)和疟原虫半胱氨酸蛋白酶-3(FP-3)具有很强的抑制作用,并能抑制体外恶性疟原虫的发育。一些化合物对氯喹抑制 3D7 株恶性疟原虫的抑制作用与氯喹相当,对氯喹耐药的 DD2 寄生虫仍保持很强的活性。这些化合物为开发新型抗疟药物提供了有希望的先导化合物。

相似文献

1
Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.合成鸡蛋白氨酸酰胺 A 类似物作为有效的疟原虫蛋白酶抑制剂和抗疟药物。
J Med Chem. 2014 Dec 26;57(24):10557-63. doi: 10.1021/jm501439w. Epub 2014 Dec 8.
2
A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.恶性疟原虫半胱氨酸蛋白酶(恶性疟原虫蛋白酶-2)的前结构域肽可抑制疟原虫发育。
J Med Chem. 2008 Jun 12;51(11):3116-23. doi: 10.1021/jm070735f. Epub 2008 May 8.
3
Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.鉴定新型疟原虫蛋白酶-2抑制剂作为潜在抗疟药物
Bioorg Med Chem. 2015 May 1;23(9):2221-40. doi: 10.1016/j.bmc.2015.02.062. Epub 2015 Mar 18.
4
Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.哒嗪并[1,2-a]嘧啶-4-酮类作为抗疟原虫 falcipain-2 抑制剂。
Bioorg Med Chem. 2012 Nov 1;20(21):6296-304. doi: 10.1016/j.bmc.2012.09.008. Epub 2012 Sep 13.
5
Identification of diverse natural products as falcipain-2 inhibitors through structure-based virtual screening.通过基于结构的虚拟筛选鉴定多种天然产物作为疟原虫蛋白酶-2抑制剂。
Bioorg Med Chem Lett. 2014 Mar 1;24(5):1261-4. doi: 10.1016/j.bmcl.2014.01.074. Epub 2014 Feb 2.
6
Falcipain Inhibitors Based on the Natural Product Gallinamide A Are Potent in Vitro and in Vivo Antimalarials.基于天然产物鸡纳酰胺 A 的疟原虫蛋白酶抑制剂在体外和体内均具有强大的抗疟效果。
J Med Chem. 2019 Jun 13;62(11):5562-5578. doi: 10.1021/acs.jmedchem.9b00504. Epub 2019 May 22.
7
Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2.噻唑烷二酮类化合物作为恶性疟原虫半胱氨酸蛋白酶 falcipain-2 的抗疟抑制剂的合成及构效关系研究。
Eur J Med Chem. 2015 Jan 27;90:507-18. doi: 10.1016/j.ejmech.2014.11.061. Epub 2014 Dec 2.
8
Design, synthesis and biological evaluation of functionalized phthalimides: a new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite.功能化邻苯二甲酰亚胺的设计、合成及生物学评价:一类新型抗疟药及疟原虫主要血红蛋白酶-2(falcipain-2)的抑制剂
Bioorg Med Chem. 2015 Apr 15;23(8):1817-27. doi: 10.1016/j.bmc.2015.02.029. Epub 2015 Feb 24.
9
Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.恶性疟原虫半胱氨酸蛋白酶的吩噻嗪抑制剂的合成及其抗疟作用
J Med Chem. 1997 Aug 15;40(17):2726-32. doi: 10.1021/jm970266p.
10
Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials.设计、合成及 3-亚甲基取代的吲哚啉酮类抗疟药物的评价。
Eur J Med Chem. 2011 Mar;46(3):927-33. doi: 10.1016/j.ejmech.2011.01.008. Epub 2011 Jan 15.

引用本文的文献

1
Total Synthesis of Kavaratamides A-C and Unnatural Analogs.卡瓦酰胺A - C及非天然类似物的全合成
ACS Omega. 2025 Jun 13;10(24):26052-26060. doi: 10.1021/acsomega.5c02929. eCollection 2025 Jun 24.
2
Marine Cyanobacteria: A Rich Source of Structurally Unique Anti-Infectives for Drug Development.海洋蓝细菌:用于药物开发的结构独特抗感染药物的丰富来源。
Molecules. 2024 Nov 10;29(22):5307. doi: 10.3390/molecules29225307.
3
Sulfonamide based pyrimidine derivatives combating parasite by inhibiting falcipains-2 and falcipains-3 as antimalarial agents.
基于磺胺的嘧啶衍生物作为抗疟药,通过抑制疟原虫蛋白酶-2和疟原虫蛋白酶-3来对抗寄生虫。
RSC Adv. 2024 Aug 7;14(34):24725-24740. doi: 10.1039/d4ra04370g. eCollection 2024 Aug 5.
4
Nature-Inspired Gallinamides Are Potent Antischistosomal Agents: Inhibition of the Cathepsin B1 Protease Target and Binding Mode Analysis.受自然启发的 Gallinamides 是有效的抗血吸虫药物:对组织蛋白酶 B1 蛋白酶靶标的抑制作用及结合模式分析。
ACS Infect Dis. 2024 Jun 14;10(6):1935-1948. doi: 10.1021/acsinfecdis.3c00589. Epub 2024 May 17.
5
Reinvestigation of diphenylmethylpiperazine analogues of pyrazine as new class of cysteine protease inhibitors for the treatment of malaria.重新研究吡嗪的二苯甲基哌嗪类似物作为治疗疟疾的新型半胱氨酸蛋白酶抑制剂。
RSC Med Chem. 2024 Feb 1;15(3):1022-1037. doi: 10.1039/d3md00490b. eCollection 2024 Mar 20.
6
An Overview on Antimalarial Peptides: Natural Sources, Synthetic Methodology and Biological Properties.抗疟肽概述:天然来源、合成方法学及生物学特性。
Molecules. 2023 Nov 25;28(23):7778. doi: 10.3390/molecules28237778.
7
Drug Discovery Efforts to Identify Novel Treatments for Neglected Tropical Diseases - Cysteine Protease Inhibitors.药物研发努力:寻找新型治疗方法以应对被忽视的热带病——半胱氨酸蛋白酶抑制剂。
Curr Med Chem. 2024;31(16):2170-2194. doi: 10.2174/0109298673249097231017051733.
8
Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?三十年靶向疟原虫裂殖体蛋白研发抗疟药物:我们从中得到了哪些启示,下一步该怎么做?
Curr Med Chem. 2024;31(16):2234-2263. doi: 10.2174/0929867331666230913165219.
9
Covalent Inhibitors for Neglected Diseases: An Exploration of Novel Therapeutic Options.用于被忽视疾病的共价抑制剂:新型治疗选择的探索
Pharmaceuticals (Basel). 2023 Jul 19;16(7):1028. doi: 10.3390/ph16071028.
10
Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19.一些具有强大的抗SARS-CoV-2和抗蛋白酶活性的天然化合物及其类似物,可作为COVID-19药物研发中的先导分子。
Eur J Med Chem Rep. 2022 Dec;6:100079. doi: 10.1016/j.ejmcr.2022.100079. Epub 2022 Aug 28.